These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12813810)

  • 81. HIV Glasgow 2018, 28-31 October 2018, Glasgow, UK.
    J Int AIDS Soc; 2018 Oct; 21 Suppl 8(Suppl Suppl 8):e25187. PubMed ID: 30362663
    [No Abstract]   [Full Text] [Related]  

  • 82. Highlights from HIV Glasgow, 28-31 October 2018, Glasgow, UK.
    Psomas CK; Philibert P; Kinloch S
    J Virus Erad; 2019 Jan; 5(1):67-72. PubMed ID: 30800430
    [No Abstract]   [Full Text] [Related]  

  • 83. Report of Diseases among the Poor of Glasgow, during February, March, and April, 1828.
    Stirling J
    Glasgow Med J; 1828 Aug; 1(3):333-338. PubMed ID: 30431758
    [No Abstract]   [Full Text] [Related]  

  • 84. Report of the Diseases Which Prevailed among the Poor of Glasgow, during February, March, and April, 1829.
    Macfarlane J
    Glasgow Med J; 1829 Aug; 2(7):330-335. PubMed ID: 30431836
    [No Abstract]   [Full Text] [Related]  

  • 85. Report of Diseases among the Poor of Glasgow, during February, March, and April, 1830.
    Young W
    Glasgow Med J; 1830 Aug; 3(11):330-331. PubMed ID: 30431852
    [No Abstract]   [Full Text] [Related]  

  • 86. Report of Diseases among the Poor of Glasgow, during February, March, and April, 1831.
    Stirling J
    Glasgow Med J; 1831 Aug; 4(15):337-338. PubMed ID: 30432056
    [No Abstract]   [Full Text] [Related]  

  • 87. Report of Diseases among the Poor of Glasgow, during the Months of Feb., March, and April, 1832.
    Easton JA
    Glasgow Med J; 1832 Nov; 5(20):441. PubMed ID: 30432252
    [No Abstract]   [Full Text] [Related]  

  • 88. Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.
    Harman S; Herrera C; Armanasco N; Nuttall J; Shattock RJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2347-56. PubMed ID: 22330930
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.
    Nuesch R; Geigy N; Schaedler E; Battegay M
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):684-7. PubMed ID: 12373504
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
    Fox R; Gourlay YJ
    Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.